NDRA - ENDRA Life Sciences Inc

Momentum: Bearish

Recent News

What Makes ENDRA Life Sciences ( NDRA ) a New Strong Buy Stock

Zacks Commentary • 7 months, 2 weeks ago • score: 0.34

ENDRA Life Sciences (NDRA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Bullish

Why ENDRA Life Sciences ( NDRA ) Stock Is Up 140% - ENDRA Life Sciences ( NASDAQ:NDRA )

Benzinga • 10 months, 3 weeks ago • score: 0.27

ENDRA Life Sciences Inc NDRA shares are trading higher by 94.6% to 43 cents during Tuesday's session after the company announced the activation of a post market clinical study of the TAEUS liver system. What To Know: ENDRA Life Sciences has announced the launch of a post-market clinical study at ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company is headquartered in Ann Arbor, Michigan.

52W High

$14.63

52W Low

$2.90

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

-0.14

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-0.11

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

2.18

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

2.25%

Institutions (25–75% balanced)

0.63%

Shares Outstanding

752,760

Float

752,660

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-60.23

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-1.68%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-0.1426

-0.2032

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025